Atlas Trials

Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine

Clinical trial NCT06916884 · COMPLETED

Trial details

NCT number
NCT06916884
Sponsor
Laboratorios Silanes S.A. de C.V.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2024-11-11
Primary completion
2025-10-15
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.